# Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)

> **NCT01588470** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 130 (actual)

## Conditions studied

- Type 2 Diabetes
- Coronary Heart Disease

## Interventions

- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT01588470
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588470, "Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01588470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*